TREATMENT OUTCOMES IN PERINATAL WOMEN WITH COVID-19 PNEUMONIA

Objective: to study the results of treatment of pregnant women with COVID-19 pneumonia. Material and methods. The results of examination and treatment of 3080 pregnant women infected with SARS-CoV-2 are included. 28.9% of women were in the first trimester of pregnancy. In the second trimester of pregnancy - 34.3% and in the third trimester - 36.8%. In the vast majority (64.3%) of cases, a moderate course of pneumonia was diagnosed. Results. The overall mortality was 2.1%. Pregnancy was completed in 435 women. Caesarean section was performed in only 73.6% (320 out of 435) of cases of delivery, while in the case of an extremely severe course of the disease, this method of delivery was used in all 74 (100%) pregnant women. The perinatal mortality rate was 8.3% (27 out of 327 live births). In particular, antenatal mortality was 4.6% (15 out of 327), intrapartum mortality - 2.4% (8 out of 327), early neonatal mortality - 1.2% (4 out of 327). Conclusion. Perinatal outcomes in women with COVID-19 pneumonia associated with anxiety and depressive disorders are characterized by a high rate of preterm birth in cases of severe and extremely severe illness